Top Markets
#1 TENDIES TENDIES +43.22%
#2 GEKKO GEKKO +43.17%
#3 Pons Pons +40.37%
#4 ADO Protocol ADO Protocol +38.68%
#5 Helium Helium +28.36%
#6 Prom Prom +24.56%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.59%
#8 o1.exchange o1.exchange +17.90%
#9 Main Street Yield Main Street Yield +17.48%
#10 Nillion Nillion +17.32%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Chengdu Kanghua Biological Products Co., Ltd. Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd.

300841
Rank in Stocks #9575
Chengdu Kanghua Biological Products Co., Ltd. engages in the research,... Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
Share Price
$7.60
Last synced: 2026-08-28
Market Cap
$987.13M
Change (1 day)
-5.04%
Change (1 year)
-28.09%
Country
CN
Trade Chengdu Kanghua Biological Products Co., Ltd. (300841)

Category

Healthcare
Revenue for Chengdu Kanghua Biological Products Co., Ltd. (300841)
Revenue in Aug 2026 TTM: 0
According to Chengdu Kanghua Biological Products Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Chengdu Kanghua Biological Products Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH